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1. Introduction: Thin polymeric film in nanomedicine 
An important and exciting direction of research in nanomedicine would be to gain a 
fundamental understanding of how living cells respond to nanostructures. At this aim, thin 
film technology plays a key role in helping to understand the cell-surface interactions. 
Generally, thin films are deposited onto bulk materials to achieve properties unattainable or 
not easily attainable in the substrate alone. In particularly, in biomedicine, polymeric thin 
films are used such as coating to improve the properties of biocompatibility, thus avoiding 
typical inflammatory response of immunitary system, especially when the system have to be 
permanently implanted (Jeong et al., 1986). 
Various biodegradable polymeric drug delivery devices have been developed for the 
sustained release of a variety of drugs, which include micro and nanoparticles, films, foams, 
wafers, discs, and micro- and nanofibers (Jain, 2000) Among them, films have gained 
growing interest in various applications. (Dorta et al., 2002; Jackson et al., 2002; Perugini et 
al., 2003; Dhanikula et al. 2004; Jackson et al. 2004; Grant et al., 2005; Alexis et al. 2005; 
Westedt et al., 2006; Heller et al.1980). For example, films for stent applications have been 
devoleped to prevent early and late complications such as thrombotic closure and restenosis 
that have been reported with all current metallic stent devices. (Westedt et al. 2006; 
Drachman et al. 2000; Alexis et al 2004, Hanefeld et al. 2006). The surfaces of most metals are 
electropositively charged and, therefore, are thrombogenic because blood elements are 
negatively charged. So the drawbacks of metallic stents have encouraged significant efforts 
to explore other materials as possible stent matrices. Alexis and colleagues studied the in 
vitro release kinetics of two important antirestenosis drugs: paclitaxel and rapamycin from 
biodegradable stent matrices. The poly(lactic-co-glycolic acid) (PLGA) and poly-DL-lactic 
acid (PDLLA) were selected in view of their relatively fast degradation rates (Alexis et al., 
2006). 
Many polymer-based implantable film formulations were developed to provide controlled, 
local release of drug for the treatment of tumors (Ho et al, 2005). Local administration of 
chemotherapeutic agents has been investigated for the treatment of various cancers, such as 
brain, prostate, esophageal, head and neck, ovarian, and breast cancer (Jeong et al., 1986; 
Webber et al., 1998; Zhou et al., 1998; McCarron et al., 2000). The implantation of a polymer-
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based device containing anti-cancer drug can provide a high-dose of chemotherapy to a 
specific area for a prolonged period of time (McCarron et al. 2000). The goal of Grant and 
collaborators, for example, was to develop a delivery system that would benefit from the 
properties of chitosan and egg phosphatidylcholine lipids, while providing a sustained 
release of therapeutically effective levels of a hydrophobic agent, paclitaxel, over several 
months (Grant et al., 2005). 
The specific combination of chitosan and egg phosphatidylcholine was found to produce 
films with a minimal degree of swelling and high stability. The chitosan lipid blend serves 
as the matrix for the delivery system, and the drug is incorporated into nanoparticles that 
are dispersed throughout the film. This film with high degree of biocompatibility was found 
to be a promising system for the localized delivery of the highly lipophilic anticancer agent. 
Another typical application of thin polymeric film in biomedicine is to prevent post surgical 
adhesions. Postsurgical adhesions are abnormal tissue attachments that may result from 
tissue abrasion during surgical procedures. Shi et al. studied biodegradable polymeric film 
formulations for the controlled delivery of paclitaxel as an effective inhibitor of the 
formation of postsurgical adhesions (Shi et al., 2004). The films were intended to provide 
both a barrier effect to separate traumatized tissues and also to release paclitaxel to inhibit 
adhesion processes.  
 
2. Neural interfaces and drug delivery system 
From the rapid growth in biotechnology, neural engineering has emerged as a new field. 
The merging of neurophysiology and engineering has resulted in approaches to link brain 
activity with man-made devices to replace lost sensory and motor function (McGee et al., 
2009). The excitement in this field is based not only on the prospect of helping a wide range 
of patients with neural disorders, but also on the certainty that this new technology will 
make possible to gain scientific insight into the way populations of neurons interact the 
complex, distributed systems that generate behaviour. 
After analytical demonstration of nerve excitation and associated action potential generation 
by Alan Hodgkin and Andrew Huxley in 1952, the possibility of using electrical 
phenomenon to cure diseases and to understand the principles of electrical nerve signals 
have been investigated through implementation of neural interfaces. 
Neural prosthetics are devices that link machines to the nervous system with the purpose of 
restoring lost functions. Two broad approaches are used in this field: neurons are stimulated 
or inhibited by applied current, or their activity is recorded to intercept motor intention. 
Stimulation can be used for its therapeutic efficacy, as in deep brain stimulation, to 
ameliorate the symptoms of Parkinson's disease or to communicate input to the nervous 
system (for example by transforming sound to neural input with cochlear prosthetics). In 
contrast, recordings are used to decode ongoing activity for use as a command or input 
signal to an external device (Schwartz et al., 2006). 
A great number of neuro-prostheses use interfaces with peripheral nerves or muscles for 
neuromuscular stimulation and signal recording. Only in this way, these new artificial 
devices can be easily incorporated into the natural control strategies of the subjects and can 
be felt as parts of their own body thanks to the sensory feedback which can be delivered 
from the sensors embedded in the robotic artefact to the nervous system. 
 
 
According to Navarro et al. 2005, a neural interface can be defined, from an engineering 
point of view, as a bidirectional transducer that establishes a contact between an artificial 
device and a neural structure within the body. On the other hand from a biological point of 
view, an interface is just a ”foreign body”. These two aspects (the engineering and the 
biological) must be both taken in high consideration and an optimized invasive neural 
interface is a compromise between the two requirements. 
The biocompatibility is the first and most important requirement for a neural interface. In 
general, the compatibility between a technical and a biological system can be divided into 
the structural biocompatibility and the surface biocompatibility (Bronzino et al. 1985). 
 
 The structural biocompatibility depends on the mechanical properties of the 
surrounding tissue and on the adaptation capability of the artificial material 
structure to the tissue. Device design and material properties should mimicry the 
biological structure of the target tissue. 
 The surface biocompatibility deals with the interaction of the chemical, physical, 
biological and morphological surface properties of the foreign material and the 
target tissue with the desired interaction. 
 
Several interfaces have been developed during the past years by many groups, applied both 
to the central nervous system (CNS, Schwartz 2004) and to the peripheral nervous system 
(PNS, Navarro et al., 2005).  
Notwithstanding the efforts carried out by several groups, the solutions developed so far 
suffer from several limitations which make very difficult the development of effective bionic 
systems. For example, cuff – and epineural - electrodes (Tarler et al., 2004) are reliable and 
robust, imply a reduced invasiveness, can be used to extract interesting information but 
suffer from a limited selectivity which is a significant drawback especially to deliver a 
sensory feedback. Intraneural PNS interfaces characterized by needles to be inserted 
longitudinally (LIFE electrodes, Lawrence et al., 2004) or transversally (USEA electrodes, 
McDonnall et al.,2004) into the PNS are very interesting combining a reduced (even if not 
absent) invasiveness with a good selectivity but their ”bandwidth” (i.e., the amount of 
information which can be exchanged between the natural and artificial systems) is still 
limited. 
Moreover, the use of these devices, and in particular microfabricated neural prostheses, is 
limited due to an inflammatory tissue reaction following implantation, which quickly 
degrades the stimulation and recording features of the device (Polikov et al., 2005). 
To avoid this phenomenon, several groups addressed their study to novel neuronal 
interfaces able of promoting neural regeneration. Anyway, the reactive tissue response of 
the brain to chronically implanted materials remains a formidable obstacle to stable 
recording from implanted microelectrodes. 
Over the course of days and weeks following implantation, a sheath of activated glia forms 
around the electrode, isolating the implanted device from the neuronal tissue (Szarowski et 
al., 2003). Studies have reported a “kill zone” around implanted devices where neuronal cell 
bodies and fibers become severely reduced in density up to 200 µm around the implantation 
site (Biran et al., 2005). The reactive tissue response includes both an acute phase, caused by 
implantation injury, and a chronic response of the tissue to the implanted material itself 
(Polikov et al., 2005). The tissue response results in a decline in availability of viable neurons 
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for recording, and a reduction in signal to noise ratio over time, which reduces or eliminates 
the ability to effectively collect recordings (Vetter et al., 2004). 
Two strategies are possible for improving the tissue response to invasive neural interfaces: 
to increase the structure biocompatibility and/or the surface biocompatibility.  
The first aspect can be achieved by the introduction of flexible interfaces. The inflammation 
at the implantation sites is thought to be aggravated by the mechanical mismatch between 
the stiff interface and the soft biological tissue. Their different mechanical properties induce 
relative drifts between the interface and the tissue encouraging the formation of a glial scar, 
which can encapsulate or break the probe with time (Cheung et al. 2006). Among the other 
materials, the polyimide has been having a great success for the development of neural 
interfaces as substrate for metal active sites and tracks. Because of its high flexibility 
(Young’s modulus between 4 and 10 GPa). If compared with silicon and silicon insulation 
(SiO2, Si3N4), it got a similar insulation resistance and dielectric strength at a lower. 
Polyimide is proved as a non-toxic material in biomedicine (Richardson et al. 1993) In 
addition, polyimide-based neural interfaces can be processed by thin film technologies 
which ensure high precision and repeatability, allows a variety of designs suitable for 
implantation in different nerves and anatomical regions, and a higher number of active sites 
can be positioned within a small surface (Stieglitz et al. 2005). As an example, polyimide-
based regenerative electrodes with a thin film structure have been allowed for much better 
regeneration than silicon dice (Lago et al. 2005) while the tf-LIFE (thin film LIFE base on 
polyimide) demonstrated a good compromise between invasiveness and selectivity (Lago et 
al. 2007).  
From the other hand, alternative strategies are focusing also on the enhancement of surface 
biocompatibility. Local drug delivery to the region surrounding the implant as a means to 
avoid tissue response phenomena is actively pursued by several groups. The basic idea is to 
release bioactive components from a polymer coating on the electrode to the damaged 
neurons in order to induce adhesion and regeneration.  
Cue et al. used electrochemical polymerization to optimize the surface of the metal electrode 
sites. Poly(3,4-ethylenedioxythiophene) (PEDOT)/poly(styrene sulfonate) (PSS) was 
electrochemically deposited on the microelectrodes of neural probes (Cue et al., 2003). The 
PEDOT/PSS coating decreases the impedance modulus and, moreover, in comparison to a 
previous study on polypyrrole, PEDOT demonstrated much better electrochemical stability 
(Cui et al, 2001). A bioactive peptide was incorporated in the PEDOT film during the 
electrochemical polymerization to be released during the in vitro tests. The coated probes 
were cultured with rat glial cells that grew on the coating area of the probes and high 
quality acute neural recordings were obtained through the coated electrodes. 
One of the limits of the use of polymer surface coating is the increasing of dimensions of the 
device, potentially adding a layer to the surface that could range from tens to hundreds of 
micrometers in thickness. The high surface area-to-volume ratio of the coatings may reduce 
the ability for sustained delivery over long periods of time, which could minimize its 
potential for limiting the chronic neuroinflammatory response. 
To overcome these disadvantages, Williams et al., presented a method for targeted 
microscale drug delivery, based on micromachined “wells” fabricated into the substrate of a 
MEMS (micro-electro-mechanical systems)- based chronic implant (Williams et al., 2005). 
These wells are holes that extend through the device thickness and allow for the integration 
of matrices (i.e., hydrogels) infused with bioactive substances. 
 
 
 Fig. 1. Illustration of electrode well seeding technique. Schematics of the device and 
pipette depicting the injection and the droplet deposition methods prior to gel loading 
are given in (A) and (B), respectively, (C) schematic of a device with a filled well, (D) 
fluorescent image of probe immediately after the gel loading and subsequent withdrawal 
of pipette tip. The edges of the probe appear red due to internal reflection of the 
fluorescent DiI emanating from the well through the polyimide substrate. The volume of 
gel contained within the well is approximately 9 pL based on the well dimensions and (E) 
shows a polyimide based electrode with a seeded well in the middle of a tetrode 
arrangement of recording sites. 
 
Since the matrices replace the substrate instead of adding to it, the device footprint is not 
increased. The lower surface area-to-volume ratio lends the technique to extended time 
release periods. Another benefit arises from the possibility of inducing cellular growth 
through the holes, which, if achievable, may serve to physically anchor the implant into the 
surrounding tissue. Particularly for electrically-based probes, any reduction of device 
movement post-implantation would aid in the localization of electrical signals and their 
subsequent assignment to individual cells. 
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 Fig. 2. Wells seeded with NGF. The upper left schematic (A) illustrates the layout of an 
implanted microelectrode array, showing the relative position of the NGF-seeded well in 
relation to a recording site. In this four-shank implant, only one of the shanks has an 
NGF-seeded well. The implanted animal was sacrificed after 40 days, sectioned at the 
level of the NGF-seeded well, and immunohistochemically stained with antibodies 
against GFAP and the extracellular matrix protein, laminin. (B) is a histological image 
from this implant. The site that contained the NGF-seeded well (second from the left in 
this image) showed increased levels of matrix deposition versus the unseeded electrode 
shank sites. (C) shows the electrophysiological recordings taken from two individual 
electrode sites closest to two different seeded wells, each at 40-days post-implantation.  
 
Qualitative observations depicted in Fig. 2B show a notable tissue response in the form of 
laminin deposition, seen as a green “cloud” over and adjacent to the site of NGF release 
from the gel. Additionally, an increased level of GFAP expression (yellow stained cells) can 
be seen around the implant sites. These results are typical for the sites of NGF seeding, but 
noticeably different from the well sites without NGF, which all showed a relatively normal 
response. A two-second sample of the extracellular recordings taken from two different 
recording sites, each located 15 μm from two different seeded wells is given in Fig. 2 C. 
These recordings demonstrate that the sites near the NGF-seeded wells remain electrically 
viable following implantation. The recordings are typical for the sites adjacent to the NGF-
seeded wells, although not statistically different from the other sites in the array. In all 
animals implanted with functioning electrodes (n = 4, 48 hours and 40 days), neural signals 
were recorded from the sites adjacent to the wells that had been seeded with bioactive 
molecules. Qualitatively, the electrodes were able to record unit activity with acceptable 
signal amplitude. 
Winter et al., have investigated the use of biodegradable, neurotrophin-eluting hydrogels 
(i.e., poly(ethylene glycol)-poly(lactic acid), PEGPLA) as a means of attracting neurites to the 
surface of stimulating electrodes. PEGPLA hydrogels with release rates ranging from 1.5 to 3 
weeks were synthesized (Winter et al, 2007). PEGPLA was selected because of the unique 
properties of the individual components. PEG has been shown to improve immune response 
to implanted elements and has been used to increase the circulation time of drugs. Thus 
PEG as a hydrogel component may reduce immune reaction to the implanted prosthesis and 
increase the circulation time of released neurotrophins associated with degrading PEG 
 
 
molecules. The PLA portion of the polymer provides biodegradability, allowing for eventual 
elimination of the polymer from the array. Additionally, the degradation rate can be used to 
regulate neurotrophin release through variations of the PEGPLA ratio. These hydrogels 
were applied to multielectrode arrays with sputtered iridium oxide charge-injection sites. 
PC12 cell cultures were exposed to NGF-releasing boluses, suspended in trans well inserts 
for 5/14 days, and compared to a positive control receiving 50 ng/mL of NGF, to a negative 
control receiving no NGF, and a to sham receiving BSA-releasing boluses. 
 
 Fig. 3. (A-E) Representative optical micrographs of PC12 Cells after 5 days with boluses 
in culture. (A) Positive control receiving 50 ng/mL NGF, (B) and (C) substrates display 
large numbers of neurites (arrows), whereas (D) negative control receiving 0 ng/mL NGF 
and (E) sham, BSA-releasing bolus display only few, short neurites. 
 
The results of this work show that PEGPLA polymers can produce controlled, sustained 
release of neurotrophins, and that these neurotrophins produce neurite extension in a 
neuronal cell culture model. 
It was also verified that these hydrogels can be applied to electrically stimulating neural 
prostheses, and do not impede the function of these devices. Thus, neurotrophin-eluting 
hydrogels provide one possible means to attract neurites to an electrical prosthesis surface, 
potentially lowering electrical stimulation thresholds. If lower thresholds can be achieved, 
larger numbers of electrodes could be driven with the same power requirements, increasing 
pixel density. These high density devices will lead to greatly improved fidelity in electrically 
evoked sensory and functional responses. 
Recently, Pierce et al used another approach to mitigate the reactive tissue response of the 
brain to chronically implanted materials. A bioactive coating in the form of an ultra-porous 
silica sol–gel was applied on the surface of silicon-based microelectrodes (Pierce et al., 2009). 
The sol–gel technique allows for application of thin films of ultraporous silica, the 
morphology of which is characterized as a flat surface with pore size and surface features 
<25nm (Jedlicka et al., 2005). The films have a thickness of approximately 100 nm. These 
ultra-porous sol–gel thin films have been shown to be excellent substrates for neuronal 
growth (Jedlicka et al., 2006, 2007a). 
In Pierce’s study the attention was centred on two features of the microelectrode: the 
adherence of the coating and the resultant changes in electrical properties. Sol–gel presence 
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properties of the individual components. PEG has been shown to improve immune response 
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increase the circulation time of released neurotrophins associated with degrading PEG 
 
 
molecules. The PLA portion of the polymer provides biodegradability, allowing for eventual 
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PC12 cell cultures were exposed to NGF-releasing boluses, suspended in trans well inserts 
for 5/14 days, and compared to a positive control receiving 50 ng/mL of NGF, to a negative 
control receiving no NGF, and a to sham receiving BSA-releasing boluses. 
 
 Fig. 3. (A-E) Representative optical micrographs of PC12 Cells after 5 days with boluses 
in culture. (A) Positive control receiving 50 ng/mL NGF, (B) and (C) substrates display 
large numbers of neurites (arrows), whereas (D) negative control receiving 0 ng/mL NGF 
and (E) sham, BSA-releasing bolus display only few, short neurites. 
 
The results of this work show that PEGPLA polymers can produce controlled, sustained 
release of neurotrophins, and that these neurotrophins produce neurite extension in a 
neuronal cell culture model. 
It was also verified that these hydrogels can be applied to electrically stimulating neural 
prostheses, and do not impede the function of these devices. Thus, neurotrophin-eluting 
hydrogels provide one possible means to attract neurites to an electrical prosthesis surface, 
potentially lowering electrical stimulation thresholds. If lower thresholds can be achieved, 
larger numbers of electrodes could be driven with the same power requirements, increasing 
pixel density. These high density devices will lead to greatly improved fidelity in electrically 
evoked sensory and functional responses. 
Recently, Pierce et al used another approach to mitigate the reactive tissue response of the 
brain to chronically implanted materials. A bioactive coating in the form of an ultra-porous 
silica sol–gel was applied on the surface of silicon-based microelectrodes (Pierce et al., 2009). 
The sol–gel technique allows for application of thin films of ultraporous silica, the 
morphology of which is characterized as a flat surface with pore size and surface features 
<25nm (Jedlicka et al., 2005). The films have a thickness of approximately 100 nm. These 
ultra-porous sol–gel thin films have been shown to be excellent substrates for neuronal 
growth (Jedlicka et al., 2006, 2007a). 
In Pierce’s study the attention was centred on two features of the microelectrode: the 
adherence of the coating and the resultant changes in electrical properties. Sol–gel presence 
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and uniformity on the probes were assessed by the preparation of a fluorescently labelled 
coating that was revealed by fluorescence micrographs. 
 
 Fig. 4. Microscopy confirms the adherence of sol–gel coatings to microelectrodes. (A) 
Bright field image of probes shows their location. (B) Fluorescent micrograph of coated 
probes. For the right probe, fluorescein salt was added to the precursor sol and was 
encapsulated throughout the coating. The left probe was coated in an unlabeled sol–gel 
as a control. The fluorescence of the right probe confirms coating adhesion. These images 
demonstrate that the silica sol–gels can be successfully applied to silicon-based 
microelectrodes and Winter confirm the ability to encapsulate molecules in the TMOS 
precursor to enable drug delivery to the implantation site. 
 
To evaluate the stability of the coating an established agarose brain model was used: the 
coating appeared unaltered after insertion into the model, demonstrating adherence of the 
coating to the probe that experiences similar mechanical stresses during surgical insertion. 
Another important evaluation concerns the electrical properties of the microelectrode. 
Without favourable electrical properties, a coating designed to mitigate the reactive tissue 
response would be of little value. The cyclic voltammetry study demonstrated that the dip-
coated, ambient-dried thin film silica sol–gel coatings do not adversely affect the electrical 
characteristics of the implantable electrodes, and it may in fact provide beneficial electrical 
properties. A major advantage of the sol–gel produced silica is a wide versatility for 
biofunctionalization. All together, these features will allow the sol–gel silica coatings to be 
used as a platform material for the mitigation of the chronic phase of the reactive tissue 
response, without causing significant detriment to the functionality of the probes. 
Green et al led a study on modified laminin peptides DEDEDYFQRYLI and DCDPGYIGSR 
used to dope poly(3,4-ethylenedioxythiophene) (PEDOT) electrodeposited on platinum (Pt) 
electrodes (Green et al, 2008).  
DCDPGYIGSR was chosen due to positive results reported by Cui et al. (Cui et al, 2003) 
DEDEDYFQRYLI, a peptide which has not previously been incorporated into conducting 
polymers, was also assessed. This peptide contains the active sequence YFQRYLI, identified 
by Tashiro et al. and reported to mediate cell attachment and promote neurite outgrowth in 
both PC12 cells and cerebellar microexplant cultures (Tashiro et al, 1998). The effect of a 
large biomolecule dopant on conducting polymer physico- chemical properties was 
established with comparison to conventionally doped PEDOT/paratoluene sulfonate (pTS). 
 
 
 
 Fig. 5. SEMs at 15,000x magnification: (A) PEDOT/pTS; (B) PEDOT/DEDEDYFQRYLI; 
(C) PEDOT/DCDPGYIGSR 
 
The resulting film was less homogeneous in microscopic appearance than the control 
PEDOT/pTS film. Doping PEDOT with laminin peptides, DEDEDYFQRYLI and 
DCDPGYIGSR, resulted in altered formation of the polymer during electrodeposition. 
The use of large synthetic peptides as anionic dopants produced a softer interface with 
improved impedance characteristics, especially in the low frequency, biologically 
significant, region. However, reduced polymer electrochemical stability and lower 
adherence of the films to the Pt electrode was observed when compared to the 
conventionally doped pTS control. The larger DEDEDYFQRYLI dopant was shown to 
reduce the efficiency of electropolymerisation and consequently this polymer presented 
lower mechanical adherence than the DCDPGYIGSR-doped PEDOT. 
The effect of peptide doped polymers on mammalian cell interactions and the cell response 
to peptides containing specific bioactive ligands was assessed using the neural-like PC12 cell 
line. 
 
 Fig. 6. Sample images of PC12 neurite outgrowth on PEDOT at 96 h post-plating with 
bare polymer (top) and adsorbed whole laminin coated polymer (bottom): A. 
PEDOT/pTS; B. PEDOT/DEDEDYFQRYLI; C. PEDOT/DCDPGYIGSR. 
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Uncoated DEDEDYFQRYLI-doped PEDOT appears to support higher neurite outgrowth 
per cell than both PEDOT/pTS and PEDOT/DCDPGYIGSR despite having the lowest 
density of attached cells. PEDOT/ DCDPGYIGSR also presented a greater neurite 
outgrowth per cell than the PEDOT/pTS control. All polymers showed a significant 
improvement in cell attachment and growth compared to the conventional Pt electrode. 
 
3. A case study: alginate coated CNT array 
 
Carbon nanotubes (CNTs) are molecular-scale tubes of graphitic carbon with outstanding 
properties. They are among the stiffest and strongest fibers known, and have remarkable 
electronic properties and many other unique characteristics. For these reasons they have 
attracted huge academic and industrial interest, with thousands of papers on nanotubes 
being published every year (Ciofani et al., 2009). 
 More recently, nanotubes formed from conductive polymers have been applied to electrode 
sites, both reducing site impedance and providing a platform for controlled drug release 
(Abidian et al., 2006; Abidian and Martin, 2008). Although many of these methods are 
promising, none have emerged as a definitive solution to the problem of reactive tissue 
response. 
The case study presented in this Section is a combination of a polymer technology and 
carbon nanotubes array for the development of a drug delivery system at cellular level. 
Starting from these preliminary results, it is possible obtain innovative neural interface that 
combine the electrical properties of carbon nanotubes with the advantage of a drug delivery 
system, to avoid the typical response of the immunitary system. 
Recently, the use of carbon nanotubes (Tasis et al, 2006) attracted significant attention of 
several groups for the development of novel neuronal interfaces (Nguyen et al., 2007 
Nguyen et al., 2006, Gabay et al., 2007). Composite materials containing multi-walled CNTs 
have shown the ability to limit astrocyte production of glial scarring, while maintaining 
good neuronal connections (McKenzie et al., 2004). 
Nguyen and collaborators found that PC12 cells cultured on PPy-coated CNT arrays 
(treated with a thin layer of collagen to promote cell adhesion) can form extended neural 
network upon differentiation. Starting from these considerations, in our laboratory we have 
proposed a combination of drug delivery system with such CNT array, exploiting a thin film 
of calcium alginate as drug reservoir embedded into the platform. 
Two in vitro assays have been performed to validate the protein release on two cell lines: 
CrFK and PC12 cell, a cell line derived from a transplantable rat pheochromocytoma that 
respond reversibly to NGF by inducing a neuronal phenotype. In its presence, these cells 
undergo a dramatic change in phenotype whereby they acquire most of the characteristic 
properties of sympathetic neurons. The polymeric film embedded in the CNT array is 
described and characterized in terms of release kinetics using bovine serum albumin as drug 
model.  
 
 
 
 Fig. 7. Schematic illustration of the proposed CNT based system 
 
Figure 7 represents the scheme of the proposed system. The main structure is composed by 
the CNT array, embedded with a thin film of alginate entrapping the drug. 
 
 Fig. 8. FIB image of the as-grown CNT array 
 
The as-grown CNT array is not stable when treated in liquid environments: during the 
drying process, CNTs irreversibly stick together to form microbundles, driven by the 
capillary force of water droplets (Figure 8). In order to avoid this phenomenon, a double 
approach was followed: SiO2 film was deposited via sputtering in order to prevent the CNT 
sticking in a liquid environment, and to improve mechanical features of CNTs. A thin layer 
of a conductive polymer, polypirrole, was deposited by electrochemical deposition in order 
to reduce the impedance of the system and to improve the recording.  
This phenomenon is completely avoided by performing a SiO2 coating. The SiO2 thin film, in 
fact, improves CNT mechanical features against the capillary force of water droplets during 
the drying process, thus preserving vertically alignment (Fig. 9b). The thin film of 
polypirrole partially avoided the problem, but it was not found satisfactory. 
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a b c
 Fig. 9. Bare (a), PPy-coated (b), and SiO2-coated (c) CNT array (samples dipped in water 
and dried in air before the imaging) 
 
Among polymers, alginate has several unique properties that have allowed using it as a 
matrix for the entrapment and/or delivery of a variety of biological agents (Chretien et al., 
2005). It is a co-polymer extracted from some types of brown algae, and it is made up of two 
uronic acids: D-mannuronic acid and L-guluronic acid. Polyvalent cations are responsible 
for interchain and intrachain reticulations because they are tied to the polymer when two 
guluronic acid residuals are close (Mikkelsen et al., 1995). The reticulation process consists of 
the simple substitution of sodium ions with calcium ions (Gombotz et al., 1998). The 
relatively mild gelation process has enabled not only proteins (Ciofani et al., 2008) but also 
cells (Murtas et al., 2005) and DNA (Kimberly et al., 2006) to be incorporated into alginate 
matrices with full retention of the biological activity. 
For drug release kinetics investigation, BSA entrapped in the film was used as “protein 
model”, as its molecular weight is similar to that one of NGF and its concentration can be 
much more easily evaluated concentration in the release bulk via spectrophotometry. 
Crosslinking was thus performed with a 30% CaCl2 solution, gently stirred and quickly 
removed (Simpson et al., 2004).  
In order to define a thickness of the film polymer comparable to the height of CNTs, 
different alginate solutions at several concentrations were tested, producing films on Si 
clean surface. Subsequently, via FIB analysis, the film thickness for the different conditions 
was measured, and finally the alginate concentration corresponding to a film thickness of 
approximately 5 µm was chosen. 
The typical temporal trend of the protein release from the alginate thin film is reported in 
Figure 10. 
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 Fig. 10. Alginate release profile: experimental data and model fitting (n =3). 
 
 
Protein amount is given as percentage of the initial amount entrapped into the film (200 µg 
per cm3 of film). The trend is well fitted (R2 =97,65%) with a bi-exponential curve as already 
reported for alginate fibers (Ciofani et al. 2008a) and microspheres (Ciofani et al., 2008b) and 
described by the following expression: 
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where C2 is the protein in the bulk, C10 is the concentration inside the gel, S and V1 are, 
respectively, the surface and the volume of film, V2 is the volume of the bulk, h is the 
massive exchange coefficient, Cs0 is the protein concentration on the surface of the film and 
finally ks is the desorption rate constant. 
Substituting known values and by fitting the experimental data with the mathematical 
model of equation (1), the h value results 10-9 m/s, in agreement with data given in the 
literature for alginate microsphere (Laca et al., 1999). 
In vitro experiments were carried out on two cell lines: in preliminary assays feline nephritic 
fibroblasts (CrFK) were used just to validate the diffusion of the drug in the bulk and the 
up-take by the cells. Other salient responses to NGF include cessation of proliferation, 
generation of long neurites, acquisition of electrical excitability, hypertrophy and a number 
of changes in composition associated with acquisition of a neuronal phenotype (Greene et 
al., 1998) 
 
 Fig. 11. Fluorescent microscopy of CrFK cells onto SiO2 (left) of PPy (right) coated CNT 
interface entrapping fluoscent BSA coniugate after six hours of incubation 
 
Figure 11 shows fluorescent microscopy images of CrFK cells after six hours of incubation 
onto CNT array coated with SiO2 and PPy, respectively. These results demonstrate that the 
FITC-BSA, embedded in the alginate film, is efficiently released and internalized by the 
cells. 
Alginate film coated on the CNT array and entrapping NGF was finally tested on PC12 cells 
monitoring their differentiation. An alginate solution entrapping 2 nM of NGF was casted 
on the CNT array and thereafter crosslinked with a 30% CaCl2 solution as previously 
reported. PC12 cells were seeded on an ad hoc polystyrene substrate, fabricated with high 
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precision milling machine, at a density of 50,000/cm2. The substrate was thereafter placed 
on the CNT array system and the cells were grown in differentiating medium. 
Figure 12 shows clearly differentiated PC12 cells after incubation on the CNT array coated 
with the releasing film. The microscope analysis was carried out up to three days of 
incubation, and, specifically, after 8 (Figure 12a), 24 (Figure 12b), 48 (Figure 12c) and finally 
after 72 hours (Figure 12d). Number of differentiated cells incremented during the time: at 
the third day of culture, the PC12 cells generate a neural network, that is a clear 
demonstration that the NGF is released from the film and still maintained its bioactivity. 
 
 Fig. 12. Differentiating PC12 cells after 8 (a), 24 (b), 48 (c) and 72 h (d) 
 
Fig. 13a and 13b show, respectively, the percentage of differentiated cells and the neurite 
length at the different time points. Figure 6a shows that already after eight hour, a non 
negligible number of cells, about the 10%, are differentiated. After 24 h there is a spread of 
the number of differentiated cells, about the 85% of the total cells. In the second day, the 
number increased up to 90% and, in the third day, about 96% of the cells presented well 
developed neurites. Figure 6b reports the trend of neurite length in the time: already after 24 
hours, the mean length of the neurite is 30 ±17.9 µm and after 72 hours the length increases 
up to 28 ±15.9 µm. 
 
 
 
 
 Fig. 13. Percentage of differentiated cells (a) and neurite length (b) vs. time (n = 3) 
 
These data do not significantly differ (p > 0.1, Student’s t-test) from control tests performed 
with “free” NGF (80 ng/ml in the culture medium) where, after three days of incubation, 
almost 95% of cell were differentiated with an average neurite length of about 30 µm. 
 
4. Conclusion 
Drug delivery to the central nervous system (CNS) remains a challenge despite advances in 
understanding the mechanisms involved in the development of neurodegenerative 
disorders and the actions of neuroactive agents. Drug accessibility to the CNS is limited by 
the blood-brain barrier; moreover the systemic administration of neuroactive biomolecules 
to support neuronal regeneration has several intrinsic problems, including the toxicity and 
poor stability associated with many bioactive factors (Maysinger et al., 1997). 
A variety of techniques to deliver therapeutics to the CNS has been established, including 
osmotic pumps (Lewin et al., 1997) and silicone reservoirs. However, pumps frequently 
become clogged, thus limiting their ability to sustain effective concentrations; moreover 
these methods are often associated to highly invasive drawbacks, including device failure 
and higher potentials for inflammation and infection due to their non degradable 
components. Polymeric delivery systems have the potential to maintain therapeutic levels of 
a drug, to reduce side effects and to facilitate the delivery of drugs with short in vivo half-
lives. 
In this Chapter we have outlined different applications of polymers, usually intended as 
agent acted to improve the biodistribution of the desired drugs. Namely, we have 
highlighted the huge possibilities offered by the thin film technology applied to the concepts 
of “drug delivery” and “drug targeting”. After a summary of the most relevant examples in 
the literature, we described the ongoing work in our lab, aimed at obtaining an efficient 
combination of physical and chemical features of an innovative neuronal interface based on 
a carbon nanotubes array. 
The achieved results indicate that polymer technology could be efficiently embedded in 
CNT array (Hind et al., 2004) acting as drug delivery system at cellular level. The implication 
of this study open several perspectives in particular in the field of neurointerfaces, 
combining several functions into a single platform (Navarro et al., 1998; Navarro et al., 2005). 
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precision milling machine, at a density of 50,000/cm2. The substrate was thereafter placed 
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 Fig. 12. Differentiating PC12 cells after 8 (a), 24 (b), 48 (c) and 72 h (d) 
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the number of differentiated cells, about the 85% of the total cells. In the second day, the 
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developed neurites. Figure 6b reports the trend of neurite length in the time: already after 24 
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up to 28 ±15.9 µm. 
 
 
 
 
 Fig. 13. Percentage of differentiated cells (a) and neurite length (b) vs. time (n = 3) 
 
These data do not significantly differ (p > 0.1, Student’s t-test) from control tests performed 
with “free” NGF (80 ng/ml in the culture medium) where, after three days of incubation, 
almost 95% of cell were differentiated with an average neurite length of about 30 µm. 
 
4. Conclusion 
Drug delivery to the central nervous system (CNS) remains a challenge despite advances in 
understanding the mechanisms involved in the development of neurodegenerative 
disorders and the actions of neuroactive agents. Drug accessibility to the CNS is limited by 
the blood-brain barrier; moreover the systemic administration of neuroactive biomolecules 
to support neuronal regeneration has several intrinsic problems, including the toxicity and 
poor stability associated with many bioactive factors (Maysinger et al., 1997). 
A variety of techniques to deliver therapeutics to the CNS has been established, including 
osmotic pumps (Lewin et al., 1997) and silicone reservoirs. However, pumps frequently 
become clogged, thus limiting their ability to sustain effective concentrations; moreover 
these methods are often associated to highly invasive drawbacks, including device failure 
and higher potentials for inflammation and infection due to their non degradable 
components. Polymeric delivery systems have the potential to maintain therapeutic levels of 
a drug, to reduce side effects and to facilitate the delivery of drugs with short in vivo half-
lives. 
In this Chapter we have outlined different applications of polymers, usually intended as 
agent acted to improve the biodistribution of the desired drugs. Namely, we have 
highlighted the huge possibilities offered by the thin film technology applied to the concepts 
of “drug delivery” and “drug targeting”. After a summary of the most relevant examples in 
the literature, we described the ongoing work in our lab, aimed at obtaining an efficient 
combination of physical and chemical features of an innovative neuronal interface based on 
a carbon nanotubes array. 
The achieved results indicate that polymer technology could be efficiently embedded in 
CNT array (Hind et al., 2004) acting as drug delivery system at cellular level. The implication 
of this study open several perspectives in particular in the field of neurointerfaces, 
combining several functions into a single platform (Navarro et al., 1998; Navarro et al., 2005). 
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